MedTrace Logo

To Decrease Fatigue With Light Therapy

NCT03242902 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2020-09-01

No results posted yet for this study

Summary

Cancer related fatigue (CRF) is one of the most prevalent and distressing long-term complaints reported by (non-) Hodgkin survivors. The SPARKLE study will test the efficacy of two intensities of light therapy on cancer related fatigue. Additionally, it explores possible working mechanisms of light therapy on CRF including improvements in sleep quality, psychosocial variables (depression, anxiety, cognitive complaints, and quality of life), and changes in biological circadian rhythms.

Conditions

Interventions

DEVICE

Light therapy intensity 1

Exposure to white light (10.000 lux) in the morning

DEVICE

Light therapy intensity 2

Exposure to white light (10-20 lux) in the morning

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Eveline Bleiker, PhD · The Netherlands Cancer Institute

  • Flora van Leeuwen, Prof.dr.ir. · The Netherlands Cancer Institute

  • Laurien Daniels, PhD, MD · Leiden University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-20
Primary Completion
2019-11-25
Completion
2020-08-11

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242902 on ClinicalTrials.gov